Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.41 |
| ▸ | MEN1 | O00255 | 3/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.41 |
| ▸ | GAA | P10253 | 2/20 | 0.39 |
| ▸ | GBA1 | P04062 | 1/20 | 0.38 |
| ▸ | CA2 | P00918 | 5/20 | 0.38 |
| ▸ | CA1 | P00915 | 4/20 | 0.38 |
| ▸ | MMP1 | P03956 | 1/20 | 0.38 |
| ▸ | MMP2 | P08253 | 1/20 | 0.38 |
| ▸ | MMP9 | P14780 | 1/20 | 0.38 |
| ▸ | MMP8 | P22894 | 1/20 | 0.38 |
| ▸ | MMP13 | P45452 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
| ▸ | DHODH | Q02127 | 1/20 | 0.37 |
| ▸ | CA9 | Q16790 | 4/20 | 0.37 |
| ▸ | CA12 | O43570 | 2/20 | 0.37 |
| ▸ | VDR | P11473 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL863216 | 1.00 | ALDH1A1 (0.41) | ALDH1A1MEN1KMT2AGAAGBA1 | |
| SCHEMBL10482932 | 1.00 | ALDH1A1 (0.41) | ALDH1A1MEN1KMT2AGAAGBA1 | |
| SCHEMBL5831287 | 0.90 | GAA (0.45) | ALDH1A1MEN1KMT2AGAAGBA1 | |
| SCHEMBL17404667 | 0.90 | GAA (0.45) | ALDH1A1MEN1KMT2AGAAGBA1 | |
| SCHEMBL18737643 | 0.90 | GAA (0.45) | ALDH1A1MEN1KMT2AGAAGBA1 | |
| SCHEMBL16424498 | 0.90 | GAA (0.45) | ALDH1A1MEN1KMT2AGAAGBA1 | |
| SCHEMBL14778372 | 0.90 | GAA (0.45) | ALDH1A1MEN1KMT2AGAAGBA1 | |
| SCHEMBL14778447 | 0.88 | CA2 (0.46) | ALDH1A1MEN1KMT2AGAAGBA1 | |
| SCHEMBL18718195 | 0.88 | CA2 (0.46) | ALDH1A1MEN1KMT2AGAAGBA1 | |
| Phosphine SCHEMBL3415127 | 0.86 | CA2 (0.45) | ALDH1A1MEN1KMT2AGAAGBA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8143432-B2 | Process for regioselective mono-tosylation of diols | JANSSEN PHARMACEUTICA N.V. (BE) | 2012-03-27 | — | — | US | disclosed |
| US-20100016623-A1 | PROCESS FOR REGIOSELECTIVE MONO-TOSYLATION OF DIOLS | JANSSEN PHARMACEUTICA NV (BE) | 2010-01-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100016623-A1 | PROCESS FOR REGIOSELECTIVE MONO-TOSYLATION OF DIOLS | TREH, AGL, DGAT2 | ALDH1A1 262/4885MEN1 732/4885KMT2A 1603/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.